BMJ  2006;332:878-882 (15 April), doi:10.1136/bmj.38766.624097.1F (published 1 March 2006)

Research

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

Johan Sundström, associate professor of cardiovascular epidemiology1, Ulf Risérus, postdoctoral research fellow2, Liisa Byberg, postdoctoral research fellow2, Björn Zethelius, postdoctoral research fellow2, Hans Lithell, professor of geriatrics2, Lars Lind, professor of cardiovascular medicine1

1 Department of Medical Sciences, Uppsala University Hospital; SE-751 85 Uppsala, Sweden,, 2 Department of Public Health and Caring Sciences, Uppsala University Hospital

Correspondence to: J Sundström johan.sundstrom{at}medsci.uu.se

Abstract

Objectives To find out if the presence of the metabolic syndrome increases the risk of subsequent total and cardiovascular mortality, taking into account established risk factors for cardiovascular disease.

Design Prospective cohort study.

Setting General population.

Participants A community based sample of 2322 men followed since 1970 for a maximum of 32.7 years, investigated at ages 50 and 70.

Main outcome measures The relations of the metabolic syndrome defined by the national cholesterol education programme (NCEP) of the US National Heart, Lung, and Blood Institute or criteria of the World Health Organization (WHO) to subsequent total and cardiovascular mortality.

Results When adding the metabolic syndrome to models with established risk factors for cardiovascular disease (smoking, diabetes, hypertension, and serum cholesterol) at age 50, presence of the metabolic syndrome as defined in the NCEP significantly predicted total and cardiovascular mortality (Cox proportional hazard ratios 1.36, 95% confidence interval 1.17 to 1.58; and 1.59, 1.29 to 1.95, respectively). The metabolic syndrome added prognostic information to that of the established risk factors for cardiovascular disease (likelihood ratio tests, P < 0.0001 for both outcomes). Similar results were obtained in a subsample without diabetes or manifest cardiovascular disease.

Conclusions In a large, community based sample of middle aged men, the presence of the metabolic syndrome according to the definition of the NCEP gave long term prognostic information regarding total and cardiovascular mortality if the status of established risk factors for cardiovascular disease was known. If confirmed this may indicate clinical value in diagnosing the metabolic syndrome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Predictive value of metabolic syndrome is not clear
Richard J Jarrett
BMJ 2006 332: 1036. [Extract] [Full Text]

Presence of metabolic syndrome improves mortality risk prediction
BMJ 2006 332: 0. [Full Text]

This article has been cited by other articles:

  • Sabio, J., Zamora-Pasadas, M, Jimenez-Jaimez, J, Albadalejo, F, Vargas-Hitos, J, Rodriguez del Aguila, M., Hidalgo-Tenorio, C, Gonzalez-Gay, M., Alonso, J. (2008). Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus 17: 849-859 [Abstract]  
  • de Kroon, M. L. A., Renders, C. M., Kuipers, E. C. C., van Wouwe, J. P., van Buuren, S., de Jonge, G. A., Hirasing, R. A. (2008). Identifying metabolic syndrome without blood tests in young adults--The Terneuzen Birth Cohort. Eur J Public Health 0: ckn056v1-ckn056 [Abstract] [Full text]  
  • Mozaffarian, D., Kamineni, A., Prineas, R. J., Siscovick, D. S. (2008). Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study. Arch Intern Med 168: 969-978 [Abstract] [Full text]  
  • Chandola, T., Britton, A., Brunner, E., Hemingway, H., Malik, M., Kumari, M., Badrick, E., Kivimaki, M., Marmot, M. (2008). Work stress and coronary heart disease: what are the mechanisms?. Eur Heart J 29: 640-648 [Abstract] [Full text]  
  • Maalouf, N. M., Cameron, M. A., Moe, O. W., Adams-Huet, B., Sakhaee, K. (2007). Low Urine pH: A Novel Feature of the Metabolic Syndrome. CJASN 2: 883-888 [Abstract] [Full text]  
  • Ninomiya, T., Kubo, M., Doi, Y., Yonemoto, K., Tanizaki, Y., Rahman, M., Arima, H., Tsuryuya, K., Iida, M., Kiyohara, Y. (2007). Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population: The Hisayama Study. Stroke 38: 2063-2069 [Abstract] [Full text]  
  • Jeppesen, J., Hansen, T. W., Rasmussen, S., Ibsen, H., Torp-Pedersen, C., Madsbad, S. (2007). Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease: A Population-Based Study. J Am Coll Cardiol 49: 2112-2119 [Abstract] [Full text]  
  • Shimizu, H., Inoue, K., Mori, M. (2007). The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 193: 1-9 [Abstract] [Full text]  
  • Grundy, S. M. (2007). Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor. J. Clin. Endocrinol. Metab. 92: 399-404 [Abstract] [Full text]  
  • Lorenzo, C., Williams, K., Hunt, K. J., Haffner, S. M. (2007). The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care 30: 8-13 [Abstract] [Full text]  
  • Perel, P., Langenberg, C., Ferrie, J., Moser, K., Brunner, E., Marmot, M. (2006). Household Wealth and the Metabolic Syndrome in the Whitehall II Study. Diabetes Care 29: 2694-2700 [Abstract] [Full text]  
  • Wiberg, B., Sundstrom, J., Arnlov, J., Terent, A., Vessby, B., Zethelius, B., Lind, L. (2006). Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up. Stroke 37: 2898-2903 [Abstract] [Full text]  
  • Ingelsson, E, Arnlov, J, Lind, L, Sundstrom, J (2006). Metabolic syndrome and risk for heart failure in middle-aged men. Heart 92: 1409-1413 [Abstract] [Full text]  
  • Sundstrom, J., Vallhagen, E., Riserus, U., Byberg, L., Zethelius, B., Berne, C., Lind, L., Ingelsson, E. (2006). Risk Associated With the Metabolic Syndrome Versus the Sum of Its Individual Components. Diabetes Care 29: 1673-1674 [Full text]  
  • Jarrett, R. J (2006). Predictive value of metabolic syndrome is not clear.. BMJ 332: 1036-1036 [Full text]  
  • Farmer, A. (2006). Metabolic syndrome and mortality.. BMJ 332: 882-882 [Full text]  

Rapid Responses:

Read all Rapid Responses

The Metabolic Syndrome: a description in evolution
George I. Varughese, et al.
bmj.com, 14 Mar 2006 [Full text]
Metabolic Syndrome
Richard J Jarrett
bmj.com, 18 Apr 2006 [Full text]
The metabolic syndrome vs. main cardiovascular risk factors: Comparing apples and pears
Pascal Bovet, et al.
bmj.com, 24 May 2006 [Full text]
Early warning for use in primary care to inform patients of risk
Rupert A Gude
bmj.com, 5 Jun 2006 [Full text]



Student BMJ

Asylum seekers' care

UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care

www.student.bmj.com

Listen to the latest BMJ Interview